I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| amacrine cell | 4 studies | 24% ± 7% | |
| retina horizontal cell | 4 studies | 23% ± 6% | |
| GABAergic neuron | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| amacrine cell | 4 studies | 24% ± 7% | |
| retina horizontal cell | 4 studies | 23% ± 6% | |
| GABAergic neuron | 3 studies | 26% ± 9% |
Insufficient scRNA-seq data for expression of KCNAB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 1616.15 | 2605 / 2642 | 99% | 6.61 | 696 / 705 |
| ovary | 98% | 474.12 | 177 / 180 | 63% | 1.59 | 271 / 430 |
| uterus | 99% | 2494.81 | 169 / 170 | 59% | 2.30 | 270 / 459 |
| pancreas | 87% | 144.03 | 286 / 328 | 63% | 1.33 | 113 / 178 |
| prostate | 98% | 586.97 | 239 / 245 | 51% | 0.97 | 257 / 502 |
| lung | 98% | 290.99 | 567 / 578 | 47% | 1.09 | 546 / 1155 |
| kidney | 100% | 341.81 | 89 / 89 | 37% | 0.76 | 337 / 901 |
| skin | 92% | 233.08 | 1657 / 1809 | 42% | 1.17 | 196 / 472 |
| thymus | 100% | 439.19 | 651 / 653 | 33% | 0.82 | 202 / 605 |
| bladder | 76% | 164.71 | 16 / 21 | 54% | 1.39 | 272 / 504 |
| breast | 97% | 257.26 | 445 / 459 | 29% | 0.57 | 327 / 1118 |
| esophagus | 66% | 100.04 | 958 / 1445 | 52% | 1.24 | 96 / 183 |
| intestine | 96% | 271.59 | 928 / 966 | 22% | 0.38 | 118 / 527 |
| stomach | 89% | 183.29 | 321 / 359 | 23% | 0.39 | 65 / 286 |
| spleen | 100% | 537.92 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 97% | 255.48 | 1166 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 245.51 | 853 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 64% | 86.98 | 165 / 258 | 22% | 0.51 | 50 / 230 |
| liver | 77% | 124.07 | 174 / 226 | 6% | 0.17 | 26 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 1.69 | 22 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 1.47 | 21 / 45 |
| blood vessel | 30% | 43.21 | 402 / 1335 | 0% | 0 | 0 / 0 |
| heart | 28% | 32.51 | 242 / 861 | 0% | 0 | 0 / 0 |
| muscle | 8% | 9.09 | 61 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.17 | 3 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006813 | Biological process | potassium ion transport |
| GO_1901379 | Biological process | regulation of potassium ion transmembrane transport |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008076 | Cellular component | voltage-gated potassium channel complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0015459 | Molecular function | potassium channel regulator activity |
| GO_0004033 | Molecular function | aldo-keto reductase (NADPH) activity |
| GO_0005249 | Molecular function | voltage-gated potassium channel activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| Gene name | KCNAB3 |
| Protein name | Voltage-gated potassium channel subunit beta-3 (EC 1.1.1.-) (K(+) channel subunit beta-3) (Kv-beta-3) Potassium voltage-gated channel subfamily A regulatory beta subunit 3 |
| Synonyms | KCNA3B |
| Description | FUNCTION: Accessory potassium channel protein which modulates the activity of the pore-forming alpha subunit. Alters the functional properties of Kv1.5. . |
| Accessions | I3L0P1 ENST00000303790.3 I3L4I8 ENST00000570587.5 ENST00000570852.1 O43448 |
